Two people, not a switchboard. You deal with us directly, from the first buyer conversation to the sell-through numbers a season later.
Korean and Japanese houses face this hardest of all. The product rarely needs defending — the queue outside a K-beauty door proves that. What stops a launch is everything around it: FDA registration and labelling written for a different market, a price that has to survive American margins and promotional calendars, and a shelf with nobody standing in front of it in a country where the brand has no name yet. We handle all three, and we stay for the fourth.
A buyer meeting is not a market entry. Between the first yes and a reorder sit compliance filings, price architecture, a launch plan and someone who makes sure the product actually moves. We have taken European houses through all of it, and we stay past the launch.
We have brought European houses into the U.S. market and taken American brands into channels they had never sold in — from niche fragrance to clinical skincare. Wherever a house comes from, the American shelf works the same way, and we know how.